Recent years have witnessed significant developments in the field of diabetes treatment, with a particular focus on GLP-1 receptor agonists. Among these novel therapies, retatrutide and trizepatide are emerging as https://elainepjit849720.tusblogos.com/39424494/novel-therapeutic-targets-in-diabetes-retatrutide-and-trizepatide